Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 2.9 USD -11.85% Market Closed
Market Cap: 31.3m USD

Wall Street
Price Targets

LTRN Price Targets Summary
Lantern Pharma Inc.

Wall Street analysts forecast LTRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 15.15 USD and a high forecast of 27.3 USD.

Lowest
Price Target
15.15 USD
422% Upside
Average
Price Target
22.44 USD
674% Upside
Highest
Price Target
27.3 USD
841% Upside
Lantern Pharma Inc. Competitors:
Price Targets
LGND
Ligand Pharmaceuticals Inc
44% Upside
NVAX
Novavax Inc
130% Upside
FLUO
Fluoguide AS
160% Upside
ASMB
Assembly Biosciences Inc
146% Upside
NRIX
Nurix Therapeutics Inc
216% Upside
377740
BioNote Inc
15% Upside
MGNX
MacroGenics Inc
298% Upside
GLPG
Galapagos NV
18% Upside

Revenue
Forecast

Revenue Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Lantern Pharma Inc.

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LTRN's stock price target?
Price Target
22.44 USD

According to Wall Street analysts, the average 1-year price target for LTRN is 22.44 USD with a low forecast of 15.15 USD and a high forecast of 27.3 USD.

Back to Top